Transduction for AAV with Sean Hart

Article

Chris Spivey, editorial director, speaks with Sean Hart, CEO and SCO of LumaCyte, on percent transduction for AAV measured.

Chris Spivey, editorial director, speaks with Sean Hart, CEO and SCO of LumaCyte, on percent transduction for AAV measured. The full discussion can and more can be viewed here.

Recent Videos
Preeya Beczek, managing director and co-founder of Beczek.COM, chats about industry trends from 2024 and which of those might impact the industry in 2025, including the big trend of AI.
Kate Coleman, vice president regulatory affairs, quality and compliance, Arriello, chats about industry trends and technological advances.
William K. Oh, MD
Adam Sherlock, CEO of Qinecsa, discusses the changing political landscapes in the US and Europe and how that may affect the bio/pharma industry.
Adam Sherlock, CEO of Qinecsa Solutions
Buy, Sell, Hold: Cell and Gene Therapy
Related Content
Automation Software Innovation technology on 3d electronic circuit board chip | Image Credit: © Funtap – © Funtap – Stock.Adobe.com

Progressing Toward Full Automation in Biomanufacturing

Feliza Mirasol
March 11th 2025
Article

Advances in automation technologies and bioprocessing equipment are driving fuller adoption of automation in biomanufacturing.

Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?

Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?

Feliza Mirasol
September 27th 2024
Podcast

This podcast explores the challenges of and the progress made so far by the biopharma industry toward alternative drug delivering methods for biologic drugs.

Young researcher working with chemical samples in laboratory with HPLC system and chromatography equipment | Image Credit: © BGStock72 – Stock.Adobe.com

Advantages of Single-Use Chromatography Systems for Downstream Processing

Cynthia A. Challener
March 8th 2025
Article

The benefits include reduced contamination risks, simplified validation processes, and streamlined operations.

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Felicity Thomas
May 25th 2023
Podcast

Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

EMA Approves TAKHZYRO for Additional Subcutaneous Administration Option to Treat Hereditary Angioedema

Feliza Mirasol
March 7th 2025
Article

Takeda’s TAKHZYRO (lanadelumab) is now approved in Europe as a subcutaneous injection treatment for hereditary angioedema in patients 12 years old and above and in adults.

Vaccine Production Facility. Medication Manufacturing Process. Glass Vials with Orange Caps on Conveyor Belt. Medical Ampoule Production Line at Modern Pharmaceutical Factory. | Image Credit: © IM Imagery – © IM Imagery– Stock.Adobe.com

Advancing Biotherapy Production with Continuous Manufacturing

Feliza Mirasol
March 7th 2025
Article

RNA modalities will especially benefit from fuller adoption of continuous manufacturing platforms.

© 2025 MJH Life Sciences

All rights reserved.